search icon
  • Print
  • ShareThis
  • Text Size
  • Hepatitis C Virus

    Bringing Expert Clinical Guidance to a Rapidly Changing Field

    • HCV Webinar Logo

      IDSA Knowledge Network Webinar Series

      A series of monthly, hour-long webinars for IDSA members on current recommended practices to effectively identify, treat, and manage patients infected with the hepatitis C virus.


      >> Log in to watch the webinars
    • HCV Guideline

      Expert Guidance on Treatment

      Up-to-date guidance for the treatment of HCV infection from IDSA and the American Association for the Study of Liver Diseases, in collaboration with the International Antiviral Society-USA.


    • HCV MOC

      Maintenance of Certification

      IDSA offers a Maintenance of Certification module specific to Hepatitis C.


      >> Read more about IDSA MOC modules

    Viral hepatitis is a silent epidemic. According to the United States Department of Health and Human Services, it is estimated that 2.7 to 3.9 million persons are infected with the hepatitis C virus (HCV) in the United States alone. An enormous public health danger lies in the fact that many infected patients are unaware of their diseased state. HCV's slow disease progression can lead to liver cirrhosis or hepatocellular carcinoma, which ultimately requires transplantation or causes mortality.


    HCV: Clinical Recommendations


    Up-to-date guidance for the treatment of HCV infection from IDSA and the AASLD. >> Go to

    share your story

    Get Tested

    The U.S. Preventive Services Task Force (USPSTF) recommends screening for HCV infection to adults born between 1945-1965. Read the full report >>


    Find Treatment

    State-by-state information for hepatitis C patients >>

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site